...
首页> 外文期刊>Journal of Alzheimer's disease: JAD >Multicenter Tract-Based Analysis of Microstructural Lesions within the Alzheimer's Disease Spectrum: Association with Amyloid Pathology and Diagnostic Usefulness
【24h】

Multicenter Tract-Based Analysis of Microstructural Lesions within the Alzheimer's Disease Spectrum: Association with Amyloid Pathology and Diagnostic Usefulness

机译:阿尔茨海默病谱系中微观结构病变的多中心剖析:淀粉样蛋白病理学和诊断用途

获取原文
获取原文并翻译 | 示例
           

摘要

Diffusion changes as determined by diffusion tensor imaging are potential indicators of microstructural lesions in people with mild cognitive impairment (MCI), prodromal Alzheimer's disease (AD), and AD dementia. Here we extended the scope of analysis toward subjective cognitive complaints as a pre-MCI at risk stage of AD. In a cohort of 271 participants of the prospective DELCODE study, including 93 healthy controls and 98 subjective cognitive decline (SCD), 45 MCI, and 35 AD dementia cases, we found reductions of fiber tract integrity in limbic and association fiber tracts in MCI and AD dementia compared with controls in a tract-based analysis (p < 0.05, family wise error corrected). In contrast, people with SCD showed spatially restricted white matter alterations only for the mode of anisotropy and only at an uncorrected level of significance. DTI parameters yielded a high cross-validated diagnostic accuracy of almost 80% for the clinical diagnosis of MCI and the discrimination of A beta positive MCI cases from A beta negative controls. In contrast, DTI parameters reached only random level accuracy for the discrimination between A beta positive SCD and control cases from A beta negative controls. These findings suggest that in prodromal stages of AD, such as in A beta positive MCI, multicenter DTI with prospectively harmonized acquisition parameters yields diagnostic accuracy meeting the criteria for a useful biomarker. In contrast, automated tractbased analysis of DTI parameters is not useful for the identification of preclinical AD, including A beta positive SCD and control cases.
机译:通过扩散张量成像确定的扩散变化是具有轻度认知障碍(MCI),前甲醛疾病(AD)和广告痴呆的人中微观结构病变的潜在指标。在这里,我们将主观认知投诉的分析范围扩展为广告风险阶段的MCI。在举行的271名参与者的前瞻性议程研究中,包括93个健康对照和98个主观认知下降(SCD),45 MCI和35例AD痴呆症,我们发现在MCI中肢体和关联纤维纤维纤维植物的纤维道完整性减少与基于道分析的控制相比,痴呆症(P <0.05,家庭明智误差纠正)。相比之下,SCD的人们仅在各向异性模式下显示空间限制白体改变,并且仅在未经校正的意义水平下。 DTI参数产生了高80%的高验证诊断准确度,临床诊断MCI和β阳性MCI病例的鉴别来自β阴性对照。相比之下,DTI参数仅达到了从β阴性控制的β正SCD和控制案例之间的判别的随机电平精度。这些发现表明,在AD的前阶段,例如在β阳性MCI中,具有预期谐波的采集参数的多中心DTI产生符合有用生物标记的标准的诊断准确性。相比之下,DTI参数的自动化分析对于识别临床前AD,包括β正SCD和控制案例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号